Cargando…

Mutations in the CYP27B1 gene cause vitamin D dependent rickets in pugs

Rickets is a disorder of bone development and can be the result of either dietary or genetic causes. Here, related pugs from 2 litters were included. Three pugs had clinical signs including, lameness, bone deformities, and dyspnea. One other pug was found dead. Radiographs of 2 affected pugs, 5 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohdin, Cecilia, Wang, Chao, Brander, Gustaf, Rondahl, Veronica, Karlsson, Åsa, Friling, Lisa, Fischetti, Anthony, Meadows, Jennifer, Häggström, Jens, Jäderlund, Karin Hultin, Ljungvall, Ingrid, Lindblad‐Toh, Kerstin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2023
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365047/ https://www.ncbi.nlm.nih.gov/pubmed/37293695 http://dx.doi.org/10.1111/jvim.16791

Ejemplares similares

Thoracolumbar meningeal fibrosis in pugs
por: Rohdin, Cecilia, et al.
Publicado: (2020)

High prevalence of gait abnormalities in pugs
por: Rohdin, Cecilia, et al.
Publicado: (2018)

Multiple Genetic Loci Associated with Pug Dog Thoracolumbar Myelopathy
por: Brander, Gustaf, et al.
Publicado: (2023)

Thoracolumbar myelopathies in pug dogs
por: Wachowiak, Ian J., et al.
Publicado: (2023)

Comparison of signalment and computed tomography findings in French Bulldogs, Pugs, and English Bulldogs with and without clinical signs associated with thoracic hemivertebra
por: De Decker, Steven, et al.
Publicado: (2019)

Leukocyte and cytokine variables in asymptomatic Pugs at genetic risk of necrotizing meningoencephalitis
por: Windsor, Rebecca, et al.
Publicado: (2021)

A potential early clinical phenotype of necrotizing meningoencephalitis in genetically at‐risk pug dogs
por: Windsor, Rebecca, et al.
Publicado: (2022)

Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Tidholm, A., et al.
Publicado: (2015)

Cardiac Troponin I and Amino‐Terminal Pro B‐Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease
por: Pelander, L., et al.
Publicado: (2017)

Impact of equipment and handling on systolic blood pressure measurements in conscious dogs in an animal hospital environment
por: Lyberg, Maria, et al.
Publicado: (2021)

Short‐ and long‐term outcome and magnetic resonance imaging findings after surgical treatment of thoracolumbar spinal arachnoid diverticula in 25 Pugs
por: Alisauskaite, Neringa, et al.
Publicado: (2019)

Comparison between real‐time 3‐dimensional and 2‐dimensional biplane echocardiographic assessment of left atrial volumes in dogs with myxomatous mitral valve disease
por: Tidholm, Anna, et al.
Publicado: (2019)

Real‐Time 3‐Dimensional Echocardiographic Assessment of Effective Regurgitant Orifice Area in Dogs With Myxomatous Mitral Valve Disease
por: Tidholm, A., et al.
Publicado: (2017)

Effect of feline characteristics on plasma N‐terminal‐prohormone B‐type natriuretic peptide concentration and comparison of a point‐of‐care test and an ELISA test
por: Hanås, Sofia, et al.
Publicado: (2020)

Evaluation of cardiac troponin I as a predictor of death in critically ill cats
por: Pelander, Lena, et al.
Publicado: (2023)

Comparison of the diagnostic value of symmetric dimethylarginine, cystatin C, and creatinine for detection of decreased glomerular filtration rate in dogs
por: Pelander, Lena, et al.
Publicado: (2019)

Influence of clinical setting and cat characteristics on indirectly measured blood pressure and pulse rate in healthy Birman, Norwegian Forest, and Domestic Shorthair cats
por: Hanås, Sofia, et al.
Publicado: (2021)

Effect of Breed on Plasma Endothelin‐1 Concentration, Plasma Renin Activity, and Serum Cortisol Concentration in Healthy Dogs
por: Höglund, K., et al.
Publicado: (2016)

Comparison of the mitral valve morphologies of Cavalier King Charles Spaniels and dogs of other breeds using 3D transthoracic echocardiography
por: Menciotti, Giulio, et al.
Publicado: (2018)

Effect of Body Weight on Echocardiographic Measurements in 19,866 Pure‐Bred Cats with or without Heart Disease
por: Häggström, J., et al.
Publicado: (2016)

No impact of polymorphism in the phosphodiesterase 5A gene in Cavalier King Charles Spaniels on pimobendan‐induced inhibition of platelet aggregation response
por: Reimann, Maria J., et al.
Publicado: (2023)

Tongue atrophy as a neurological finding in hereditary polyneuropathy in Alaskan malamutes
por: Hultman, Josefin, et al.
Publicado: (2022)

Left ventricular M‐mode prediction intervals in 7651 dogs: Population‐wide and selected breed‐specific values
por: Esser, Lilith Carla, et al.
Publicado: (2020)

Degenerative Encephalopathy in Nova Scotia Duck Tolling Retrievers Presenting with a Rapid Eye Movement Sleep Behavior Disorder
por: Barker, E.N., et al.
Publicado: (2016)

Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration
por: Reimann, M.J., et al.
Publicado: (2017)

Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8‐ to 10‐Year Period
por: Birkegård, A.C., et al.
Publicado: (2016)

Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels
por: Reimann, M.J., et al.
Publicado: (2017)

Polymorphisms in the serotonin transporter gene and circulating concentrations of neurotransmitters in Cavalier King Charles Spaniels with myxomatous mitral valve disease
por: Reimann, Maria J., et al.
Publicado: (2021)

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
por: Boswood, A., et al.
Publicado: (2016)

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study
por: Boswood, A., et al.
Publicado: (2017)

Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study
por: Boswood, Adrian, et al.
Publicado: (2020)

Metabolic and Hormonal Response to a Feed‐challenge Test in Lean and Overweight Dogs
por: Söder, J., et al.
Publicado: (2016)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

International collaborative study to assess cardiovascular risk and evaluate long‐term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study
por: Fox, Philip R., et al.
Publicado: (2018)

Association of Protective HLA-A With HLA-B(∗)27 Positive Ankylosing Spondylitis
por: Nordin, Jessika, et al.
Publicado: (2021)

Association of Sphingosine‐1‐phosphate (S1P)/S1P Receptor‐1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma
por: Rodriguez, A.M., et al.
Publicado: (2015)

Incidence of Diabetes Mellitus in Insured Swedish Cats in Relation to Age, Breed and Sex
por: Öhlund, M., et al.
Publicado: (2015)

Disposition of Extended Release Levetiracetam in Normal Healthy Dogs After Single Oral Dosing
por: Beasley, M.J., et al.
Publicado: (2015)

Risk Factors and Outcomes in Cats with Acquired Myasthenia Gravis (2001–2012)
por: Hague, D.W., et al.
Publicado: (2015)

Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs
por: de Araújo, M.R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5q8hdv24oh5nr999sfrs57ice3